Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Camalexin is an alkaloid released by plants of the Brassicaceae family in response to pathogen infection.1 In addition to antimicrobial properties and a role in plant defense, camalexin exhibits antiproliferative activity in vitro against various cancer cell lines.2,3,4,5 Camalexin is active against HeLa, Jurkat, MDA-MB-231, and CEM cancer cell lines (IC50s = 50.0, 46.2, 77.7, and 67.6 μM, respectively), but it is also toxic to primary human umbilical vein endothelial cells (HUVEC; (IC50 = 74.0 μM).3 Camalexin induces apoptosis in Jurkat cells by increasing reactive oxygen species (ROS) levels and activating caspase-8 and caspase-9.2 In human prostate cancer cell lines, camalexin (25 μM) is more active against aggressive lines and increases ROS levels and apoptosis via cathepsin D relocation from lysosomes to the cytosol.5,6
WARNING This product is not for human or veterinary use.
1. Phytoalexins in defense against pathogens. Trends Plant Sci. 17(2), 73-90 (2012).
2. Camalexin induces apoptosis in T-
3. In vitro toxicity of camalexin derivatives in human cancer and non-
4. The phytoalexin camalexin mediates cytotoxicity towards aggressive prostate cancer cells via reactive oxygen species. J. Nat. Med. 67(3), 607-618 (2013).
5. Camalexin-
6. Exploitation of cholane scaffold for the discovery of potent and selective farnesoid X receptor (FXR) and G-